PRIMECAP Odyssey Aggressive Growth Fund (POAGX)

Net Asset Value
1 Day
Overall Morningstar Rating
Mid-cap growth
Style or Category
No Load
Sales Expenses
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks to provide long-term capital appreciation. The fund invests primarily in the common stocks of U.S. companies, emphasizing those companies with prospects for rapid earnings growth. It may invest in stocks across all market sectors and market capitalizations and has historically invested significant portions of its assets in mid- and small-capitalization companies.


1 month+2.17% 3 years+10.77%
3 months+25.96% 5 years+12.09%
1 year+7.18% Since inception+12.99%
Data through --

Peer Comparisonvs. Mid-cap growth

Performance 5-yr return+12.09%+9.92%
Expense ratio0.64%1.17%
Risk 5 year sharpe ratio0.560.55
Net assets$9.4B$2.0B
Average market cap$12.6B$15.3B
Average P/E12.731.3
Portfolio turnover7%7%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyPRIMECAP Odyssey Funds
Fund manager & tenureTheo Kolokotrones / 15 Years
Minimal initial investment$2,000.00
Minimum IRA investment$1,000.00


U.S. stock80.47%
International stock14.87%
Fixed income0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 41.12%
Hardware 15.32%
Business service 8.51%
Telecommunication 5.89%
Industrial materials 5.31%
Top 10 Holdings
Portfolio weighting
SNE Sony4.14%
SPLK Splunk Inc3.39%
MU Micron Technology Inc3.38%
SGEN Seattle Genetics Inc3.37%
BIIB Biogen3.35%
NKTR Nektar Therapeutics2.67%
MKTX Marketaxess Holdings Inc2.51%
LLY Eli Lilly and Co2.37%
BMRN Biomarin Pharmaceutical Inc2.19%